Breast cancer is not rare. It is the most common cancer diagnosed in women worldwide, with an estimated 2.3 million new cases in 2022 alone. In the United States, about 132.5 out of every 100,000 women are diagnosed each year, and roughly 13% of women in the general population will develop breast cancer at some point in their lifetime. That said, the picture changes dramatically depending on age, sex, genetics, and the specific type of breast cancer involved.
How Common Is Breast Cancer Overall?
In countries with very high levels of development, 1 in 12 women will be diagnosed with breast cancer during their lifetime. In lower-income countries, the rate is lower at about 1 in 27, though women in those countries are more likely to die from it (1 in 48 versus 1 in 71) because of limited access to early detection and treatment.
In the U.S., the numbers are striking. An estimated 321,910 new cases are expected in 2026. As of 2023, more than 4.2 million women were living with a breast cancer diagnosis in the U.S. By any measure, breast cancer is one of the most frequently occurring cancers in the world.
Age Changes the Math Significantly
Your risk of breast cancer in any given year rises sharply with age. A woman in her 20s has an extremely low chance of being diagnosed. Breast cancer in women under 30 is genuinely rare, accounting for a very small fraction of total cases. Most breast cancers are diagnosed in women over 50, and the median age at diagnosis in the U.S. is 62.
This age pattern is one reason screening guidelines have shifted. The U.S. Preventive Services Task Force now recommends that all women begin mammography screening at age 40, repeated every two years through age 74. Previously, the recommendation was to have a personal conversation with your doctor about when to start screening sometime between 40 and 50. The task force changed its guidance after modeling showed that starting at 40 instead of 50 averts roughly 1.5 additional breast cancer deaths per 1,000 women over a lifetime and gains about 44 extra life-years per 1,000 women screened. For Black women, the benefit of starting at 40 is even more pronounced, preventing about 1.5 additional deaths and gaining over 50 extra life-years per 1,000 women compared to starting at 50.
Breast Cancer in Men
Male breast cancer is genuinely rare. About 1 out of every 100 breast cancers diagnosed in the U.S. is found in a man. In the general male population, the lifetime risk of developing breast cancer by age 70 is roughly 0.1%. Because it’s so uncommon, men often don’t consider the possibility, which can lead to later-stage diagnoses.
Men who carry inherited changes in certain high-risk genes face a meaningfully higher risk. Those with a harmful change in the BRCA2 gene have a 1.8% to 7.1% chance of developing breast cancer by age 70, which is still low in absolute terms but dramatically higher than the baseline.
Genetic Mutations and Elevated Risk
About 1 in 400 people in the general population carry a harmful change in the BRCA1 or BRCA2 gene. These mutations are uncommon, but their impact on breast cancer risk is enormous. More than 60% of women who inherit a harmful BRCA1 or BRCA2 change will develop breast cancer during their lifetime, compared to the 13% baseline risk for all women. That’s roughly a fivefold increase.
These same gene changes also raise the risk of ovarian cancer (39% to 58% lifetime risk with BRCA1, versus about 1.1% for the general population), pancreatic cancer, and prostate cancer. If you have a strong family history of breast or ovarian cancer, genetic counseling can help determine whether testing makes sense for you.
Rare Types of Breast Cancer
While breast cancer as a whole is common, certain subtypes are genuinely rare. These less common forms can behave differently from typical breast cancers and sometimes require different treatment approaches.
Inflammatory Breast Cancer
Inflammatory breast cancer accounts for 1% to 5% of all breast cancer cases. It doesn’t usually present as a lump. Instead, the breast becomes red, swollen, and warm, often resembling an infection or an insect bite. The skin may develop a dimpled, orange-peel texture. These changes progress rapidly, typically over less than three months. Because it mimics other conditions, inflammatory breast cancer is frequently misdiagnosed at first, which is concerning because it tends to be aggressive.
Paget Disease of the Breast
Paget disease makes up about 1% to 3% of all breast cancers. It starts in the nipple and appears as a scaly, red, itchy rash that can be mistaken for eczema. Most people with Paget disease also have an underlying cancer deeper in the breast tissue.
Phyllodes Tumors
Phyllodes tumors account for less than 1% of all breast tumors. They grow in the connective tissue of the breast rather than the milk ducts or lobules. The median age at diagnosis is 42 to 45, somewhat younger than for typical breast cancers. Most phyllodes tumors are benign and behave like noncancerous lumps, though they tend to recur locally after removal. Malignant phyllodes tumors are rarer still, occurring at a rate of about 2 per million women per year, and can spread to distant parts of the body.
Putting the Numbers in Perspective
Breast cancer sits in an unusual place statistically. It is far from rare as a disease. Among all cancers affecting women, it is the single most common diagnosis globally. At the same time, your individual risk in any single year, especially if you’re young, is quite low. A 30-year-old woman’s annual probability of being diagnosed is a tiny fraction of a 60-year-old’s.
The 13% lifetime figure (roughly 1 in 8 women in the U.S.) reflects cumulative risk over an entire lifespan. It does not mean that 1 in 8 women will have breast cancer at any given moment. Risk accumulates over decades, and the bulk of that risk is concentrated after age 50. This is why routine screening starting at 40, when risk begins to climb meaningfully, has the potential to catch cancers early, when survival rates are highest.